Clinical Trial Update: A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical study update for SAF-189s in NSCLC, with phases including Phase 1 and Phase 2; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SAF-189s (SAF-189s)

Snippet

Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Conditions: Advanced Cancer, Advanced Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN